
Nasus Pharma Ltd.
NSRXHealthcare|Medical - Pharmaceuticals|IL
$2.82
-0.09 (-3.09%)
DCF Value
$0.06
Tangible Book / Share
$0.99
Cash / Share
$1.07
Ownership Breakdown
33.1%
Float
8.6M
Shares Outstanding
2.9M
Float Shares
Major Holders (9)
Combined: 86.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Dr. Dalia Megiddo | Individual | 20.90% | 1,888,873 | Nov 12, 2025 | 13D/G |
| Balyasny Asset Management L.P. | IA, PN | 9.99% | 1,169,909 | Aug 14, 2026 | 13D/G |
| Bam GP LLC | HC, OO | 9.99% | 1,169,909 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management Holdings LP | HC, PN | 9.99% | 1,169,909 | Aug 14, 2026 | 13D/G |
| Dames GP LLC | HC, OO | 9.99% | 1,169,909 | Aug 14, 2026 | 13D/G |
| Dmitry Balyasny | HC, IN | 9.99% | 1,169,909 | Aug 14, 2026 | 13D/G |
| Funicular Funds, LP | Partnership | 5.20% | 612,913 | Apr 7, 2026 | 13D/G |
| Cable Car Capital, LP | IA, PN | 5.20% | 612,913 | Apr 7, 2026 | 13D/G |
| Ma-Weaver Jacob | Individual | 5.20% | 612,913 | Apr 7, 2026 | 13D/G |
Insider Trades (23)
Last 4 quarters: 24,450 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Elmaliah Oren | Interim CFO | Jun 13, 2020 | OTHER | 24,680 | $1.23 | $30.3K | Form 4 |
| Elmaliah Oren | Interim CFO | Jan 17, 2025 | OTHER | 27,460 | $6.05 | $166.0K | Form 4 |
| Rubin Eyal | officer | Sep 18, 2026 | OTHER | 0 | — | — | Form 4 |
| O'Grady Brendan P. | director, officer: Chief Executive Officer | Jul 27, 2026 | OTHER | 0 | — | — | Form 4 |
| Teleman Dan Benjamin | director, officer: Chief Executive Officer | Jul 22, 2026 | OTHER | 0 | — | — | Form 4 |
| Teleman Dan Benjamin | director, officer: Chief Executive Officer | Jun 17, 2026 | BUY | 6,550 | $3.10 | $20.3K | Form 4 |
| Teleman Dan Benjamin | director, officer: Chief Executive Officer | Apr 22, 2026 | BUY | 2,900 | $3.76 | $10.9K | Form 4 |
| Teleman Dan Benjamin | director, officer: Chief Executive Officer | Mar 31, 2026 | BUY | 15,000 | $2.04 | $30.6K | Form 4 |
| Rubin Eyal | officer, other: Chief Financial Officer | Nov 20, 2026 | OTHER | 40,549 | $7.56 | $306.6K | Form 4 |
| Silberman David | director | Mar 11, 2026 | OTHER | 10,000 | $5.38 | $53.8K | Form 4 |
| Teleman Dan Benjamin | director, officer: Chief Executive Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Teleman Dan Benjamin | director, officer: Chief Executive Officer | Jan 7, 2026 | OTHER | 318,856 | $6.05 | $1.9M | Form 4 |
| Shacham Sharon | director | Mar 11, 2026 | OTHER | 10,000 | $5.38 | $53.8K | Form 4 |
| Gilboa Udi | other: Founder & Executive Chairman | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Gilboa Udi | other: Founder & Executive Chairman | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Gilboa Udi | other: Founder & Executive Chairman | Feb 13, 2026 | OTHER | 17,970 | $6.53 | $117.3K | Form 4 |
| Hershman Ronnie | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Hershman Ronnie | director | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Hershman Ronnie | director | May 6, 2020 | OTHER | 63,017 | $4.30 | $270.8K | Form 4 |
| Hershman Ronnie | director | Feb 13, 2026 | OTHER | 17,970 | $6.53 | $117.3K | Form 4 |
| Megiddo Dalia | director, officer, other: Chief Development Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Megiddo Dalia | director, officer, other: Chief Development Officer | Mar 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Israel Isaac | director | Mar 11, 2026 | OTHER | 10,000 | $5.38 | $53.8K | Form 4 |